Real estate will prosper, small developers won't, Ajay Piramal tells Abhineet Kumar and Niraj Bhatt. IMAGE: "For larger developers, demonetisation and RERA are opportunities as the business has......
The US Federal prosecutors are seeking about $1 billion to resolve a long-running probe into healthcare giant Johnson & Johnson's marketing of the anti-psychotic drug Risperdal, says a media......
The world of big pharma and that of cultural heritage protection do not obviously overlap. But in fact there are logical connections, or so claims Dr Alex Valcke, vice president of one of the......
Mumbai-based Sun Pharmaceuticals has filed a post-grant opposition with the Mumbai patent office against a product patent granted to the extended release version of Johnson and Johnson's (J&J)......